The annual fee that you pay to the fund company for managing your investment. The lower the expense ratio, the better. This is not an investment recommendation.
People Also Follow
This list is based on the watchlists of people on Stock Events who follow W312.STU. It's not an investment recommendation.
The Harbor Health Care UCITS ETF (WELL) allows investors to access the sustained expansion and cutting-edge innovations of the U.S. healthcare system. This actively managed fund, overseen by the skilled team at Westfield Capital Management, aims to surpass the performance of the wider healthcare sector. It achieves this by focusing investments on high-caliber companies known for their distinct products, technologies, and services, ensuring they meet strict valuation standards. The strategy specifically embraces transformative themes such as targeted oncology, liquid biopsy, gene therapy, and orphan diseases, which are identified as significant drivers of long-term growth.
What is Han-Gins Indxx Healthcare Innovation UCITS - Acc stock price today?▼
The current price of W312.STU is €7.63 EUR — it has increased by +1.42% in the past 24 hours. Watch Han-Gins Indxx Healthcare Innovation UCITS - Acc stock price performance more closely on the chart.
What is Han-Gins Indxx Healthcare Innovation UCITS - Acc stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on Boerse Stuttgart exchange Han-Gins Indxx Healthcare Innovation UCITS - Acc stocks are traded under the ticker W312.STU.
In which sector is Han-Gins Indxx Healthcare Innovation UCITS - Acc located?▼
Han-Gins Indxx Healthcare Innovation UCITS - Acc operates in the Finance & Payments sector.
When did Han-Gins Indxx Healthcare Innovation UCITS - Acc complete a stock split?▼
Han-Gins Indxx Healthcare Innovation UCITS - Acc has not had any recent stock splits.
Where is Han-Gins Indxx Healthcare Innovation UCITS - Acc headquartered?▼
Han-Gins Indxx Healthcare Innovation UCITS - Acc is headquartered in Dublin 2, Ireland.